Narrow search
Showing 1 - 10 of 16
Cover Image
Specialty drug prices and utilization after loss of U.S. patent exclusivity, 2001-2007
Conti, Rena M.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2014
estimated prices of these drug undergoing LOE fall with generic entry. Second, we estimate reduced form random effects models of … utilization subsequent to LOE. We observe substantial price erosion after generic entry; average monthly price declines appear to … entry, but this result appears to be largely driven by oral drugs. We discuss second-best welfare consequences of these …
Persistent link: https://www.econbiz.de/10010950850
Cover Image
Pricing and Reimbursement in U.S. Pharmaceutical Markets
Berndt, Ernst R.; Newhouse, Joseph P. - National Bureau of Economic Research (NBER) - 2010
comment on very recent developments concerning the entry of large retailers such as Wal-Mart into domains traditionally …
Persistent link: https://www.econbiz.de/10008531891
Cover Image
The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts
Conti, Rena M.; Huskamp, Haiden A.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 2011
The US Food and Drug Administration (FDA) expends considerable efforts in regulating medications approved for use. Yet the impact of medication labeling changes on brand pharmaceutical products, and whether and what firms do to respond to increased information regarding the safety and efficacy...
Persistent link: https://www.econbiz.de/10009325511
Cover Image
Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation
Berndt, Ernst R.; Aitken, Murray L. - National Bureau of Economic Research (NBER) - 2010
following initial generic entry and by 24 months to 65, in 2009 the comparable generic price indexes are 68 and 27, respectively … patent has expired. Across all nine therapeutic areas, at 24 months post-generic entry, the weighted mean reduction in …
Persistent link: https://www.econbiz.de/10008682661
Cover Image
Costs, Institutional Mobility Barriers, and Market Structure: Advertising Agencies as Multiproduct Firms
Silk, Alvin J.; Berndt, Ernst R. - National Bureau of Economic Research (NBER) - 1994
low fixed costs and minimal entry barriers, both media-specific scale and scope economies are available and can be …
Persistent link: https://www.econbiz.de/10005248932
Cover Image
In Whom We Trust: The Role of Certification Agencies in Online Drug Markets
Bate, Roger; Jin, Ginger Zhe; Mathur, Aparna - National Bureau of Economic Research (NBER) - 2012
This paper uses an audit sample and a consumer survey to study the intriguing market of online prescription drugs facing US customers, and assesses the role that certification agencies play in online drug markets. On the supply side, we acquire samples of five popular brand-name prescription...
Persistent link: https://www.econbiz.de/10011188525
Cover Image
Banning Foreign Pharmacies from Sponsored Search: The Online Consumer Response
Chesnes, Matthew; Weijia (Daisy) Dai; Jin, Ginger Zhe - National Bureau of Economic Research (NBER) - 2014
Increased competition from the Internet has raised a concern of product quality for online prescription drugs. The Food and Drug Administration (FDA) prohibits the importation of unapproved drugs into the US and the National Association of Boards of Pharmacy (NABP) emphasizes their illegality...
Persistent link: https://www.econbiz.de/10010772576
Cover Image
Inspection Technology, Detection and Compliance: Evidence from Florida Restaurant Inspections
Lee, Jungmin; Jin, Ginger Zhe - National Bureau of Economic Research (NBER) - 2013
In this article, we show that a small innovation in inspection technology can make substantial differences in inspection outcomes. For restaurant hygiene inspections, the state of Florida has introduced a handheld electronic device, the portable digital assistant (PDA), which reminds inspectors...
Persistent link: https://www.econbiz.de/10010951300
Cover Image
Gaming in Air Pollution Data? Lessons from China
Chen, Yuyu; Jin, Ginger Zhe; Kumar, Naresh; Shi, Guang - National Bureau of Economic Research (NBER) - 2013
Protecting the environment during economic growth is a challenge facing every country. This paper focuses on two regulatory measures that China has adopted to incentivize air quality improvement: publishing a daily air pollution index (API) for major cities since 2000 and linking the API to...
Persistent link: https://www.econbiz.de/10010951438
Cover Image
Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
Philipson, Tomas; Berndt, Ernst R.; Gottschalk, Adrian H. B. - National Bureau of Economic Research (NBER) - 2004
Congress enacted and renewed the Prescription Drug User Fee Acts (PDUFA) in 1992, and renewed it in 1997 and 2002, mandating FDA performance goals in reviewing and acting on drug applications within specified time periods. In turn, the FDA was permitted to levy user fees on drug sponsors...
Persistent link: https://www.econbiz.de/10005084928